Promoting Best Practices for U.S. Regulatory Analysis
Benefit-cost analysis experts advocate changes to a draft update of OMB Circular A-4.
Clark Nardinelli
Clark Nardinelli served as the chief economist of the U.S. Food and Drug Administration and is currently a scholar at the George Washington University Regulatory Studies Center.